Le Lézard
Classified in: Health
Subjects: TDS, SCZ

Clear Arch Health RPM Solution Well Poised to Support Home Health and Home Care in 2020 and Beyond


SEATTLE, Oct. 13, 2019 /PRNewswire/ -- For attendees at the National Association for Home Care & Hospice (NAHC) annual conference, Clear Arch Health, a division of MobileHelp® and a leader in personal and enterprise healthcare technology solutions, will be showcasing MobileVitals® Touch ? the company's remote patient monitoring (RPM) solution with integrated emergency response (PERS) capabilities ? in its exhibitor booth (#227).

MobileVitals Touch

Designed to provide patients with an easy-to-use RPM solution, as well as the ability to access emergency help if they need it, the MobileVitals Touch enhances the model of care by exposing patient trends between face to face interactions.

The system's remote capture of daily physiological data such as blood pressure, weight, pulse oximetry and blood glucose levels can be incorporated into a patient's EHR and allow healthcare providers to better manage a patient's health. This is done in between visits, even when a nurse is not physically in the patient's home ? attributes that are key to long-term chronic care and capitalizing on new reimbursement opportunities. Finding solutions that reduce the cost to deliver care and yields better outcomes is a priority to home health agencies facing PDGM.

"We know RPM improves patient outcomes and satisfaction rates and lowers the costs of care," said Chris A. Otto, Senior Vice President of Clear Arch Health. "Historically, home health has always seen the value in RPM, but it has been difficult to find funding for the programs. However, we are seeing increasingly more home health agencies implement RPM programs in anticipation of Patient-Driven Groupings Model (PDGM)."

In addition to its traditional telehealth capabilities, the RPM platform offers patients the opportunity to keep the tablet and peripheral equipment. This enables patients to continue monitoring their own vital signs following clinical care episodes and it also helps to enhance long-term patient engagement.

"RPM offers a clear path to provide better quality care and higher patient engagement while simultaneously reducing cost of care, travel time and increasing workflow efficiencies," said Mr. Otto. "In addition, agencies deploying this are seeing higher rates of institutional referrals."

The MobileVitals Touch offers patients and providers a full suite of benefits, which includes:

Clear Arch Health will be showcasing the MobileVitals Touch throughout NAHC 2019, October 13-15. This year's theme "Foresight: Care for the Future" will explore the ways in which technology, models of care, policies and other factors will impact the way in which care is delivered in the home through home health and hospice agencies. For more information or to make an appointment, please visit the company website.

About Clear Arch Health:
Clear Arch Health is a division of MobileHelp®, a leading provider of remote patient monitoring (RPM) and mobile Personal Emergency Response System (mPERS) technology. Clear Arch Health provides healthcare organizations with a full range of telehealth product and service solutions designed to achieve better patient outcomes through enhanced oversight and reduced readmission. For more information about Clear Arch Health, please call 1-800-995-1854 or visit the company website at www.cleararchhealth.com.

Please direct inquiries to:
Liz Kohler, 414-828-6198
[email protected]

SOURCE Clear Arch Health


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: